Biorce accelerates clinical trial execution through Aika, the only explainable AI platform specialized with 560,000+ real trial protocols. 

While competitors offer black-box algorithms regulators can't validate, Aika provides complete transparency, every recommendation is traceable and defendable before FDA or EMA. 

Currently live: protocol design, feasibility analysis, contract negotiation and protocol evaluation. Expanding to cover the complete trial lifecycle from design through regulatory submission. 

Teams using Aika reduce protocol development time by 50% and avoid amendments that cost $400K each. 

Our human-in-the-loop architecture keeps clinical experts in control while accessing insights no single organization can replicate. 

Founded by clinical professionals who've navigated regulatory approvals firsthand, we work with pharma, biotech and CROs across oncology, neurology, rare diseases and beyond.